1117-AB74 202304 Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Federal Regulations on Telepharmacy

The Drug Enforcement Administration (DEA) is issuing this advanced notice of proposed rulemaking to obtain further information regarding the practice of telepharmacy. Telepharmacy is not specifically defined by the Controlled Substances Act (CSA) or DEA regulations; however, to the extent telepharmacies dispense controlled substances, they are under the purview of the CSA and DEA. DEA is considering promulgating regulations regarding telepharmacy and seeks to be fully informed about the practice, industry, and state regulation of telepharmacy.

]]> Other Significant Previously Published in The Unified Agenda Proposed Rule Stage No No Not Yet Determined 21 U.S.C. 822 21 U.S.C. 823 21 U.S.C. 871(b) 21 U.S.C. 958(f) No ANPRM 11/17/2021 86 FR 64096 ANPRM Comment Period End 01/18/2022 NPRM 05/00/2024 DEA Docket number 759 No No None No No DPW@dea.gov www.regulations.gov No No Scott Brinks A. Section Chief, Regulatory Drafting and Support Section, Diversion Control Division 1117 Drug Enforcement Administration DEA 571 362-8209 scott.a.brinks@dea.gov 8701 Morrissette Drive, Springfield VA 22152